Global Enasidenib Drugs Market Research Report 2024, Forecast to 2032
Report Overview
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
The global Enasidenib Drugs market size was estimated at USD 78 million in 2023 and is projected to reach USD 144.61 million by 2032, exhibiting a CAGR of 7.10% during the forecast period.
North America Enasidenib Drugs market size was estimated at USD 22.87 million in 2023, at a CAGR of 6.09% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Enasidenib Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Enasidenib Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Enasidenib Drugs market in any manner.
Global Enasidenib Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bristol Myers Squibb
Market Segmentation (by Type)
50mg
100mg
Market Segmentation (by Application)
Hospital
Pharmacy
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Enasidenib Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Enasidenib Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
The global Enasidenib Drugs market size was estimated at USD 78 million in 2023 and is projected to reach USD 144.61 million by 2032, exhibiting a CAGR of 7.10% during the forecast period.
North America Enasidenib Drugs market size was estimated at USD 22.87 million in 2023, at a CAGR of 6.09% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Enasidenib Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Enasidenib Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Enasidenib Drugs market in any manner.
Global Enasidenib Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bristol Myers Squibb
Market Segmentation (by Type)
50mg
100mg
Market Segmentation (by Application)
Hospital
Pharmacy
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Enasidenib Drugs Market
- Overview of the regional outlook of the Enasidenib Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Enasidenib Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Enasidenib Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Enasidenib Drugs
1.2 Key Market Segments
1.2.1 Enasidenib Drugs Segment by Type
1.2.2 Enasidenib Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ENASIDENIB DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Enasidenib Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Enasidenib Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ENASIDENIB DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Enasidenib Drugs Sales by Manufacturers (2019-2024)
3.2 Global Enasidenib Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Enasidenib Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Enasidenib Drugs Sales Sites, Area Served, Product Type
3.6 Enasidenib Drugs Market Competitive Situation and Trends
3.6.1 Enasidenib Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Enasidenib Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ENASIDENIB DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Enasidenib Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ENASIDENIB DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ENASIDENIB DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Enasidenib Drugs Sales Market Share by Type (2019-2024)
6.3 Global Enasidenib Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Enasidenib Drugs Price by Type (2019-2024)
7 ENASIDENIB DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Enasidenib Drugs Market Sales by Application (2019-2024)
7.3 Global Enasidenib Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Enasidenib Drugs Sales Growth Rate by Application (2019-2024)
8 ENASIDENIB DRUGS MARKET CONSUMPTION BY REGION
8.1 Global Enasidenib Drugs Sales by Region
8.1.1 Global Enasidenib Drugs Sales by Region
8.1.2 Global Enasidenib Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Enasidenib Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Enasidenib Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Enasidenib Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Enasidenib Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Enasidenib Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ENASIDENIB DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Enasidenib Drugs by Region (2019-2024)
9.2 Global Enasidenib Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Enasidenib Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Enasidenib Drugs Production
9.4.1 North America Enasidenib Drugs Production Growth Rate (2019-2024)
9.4.2 North America Enasidenib Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Enasidenib Drugs Production
9.5.1 Europe Enasidenib Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Enasidenib Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Enasidenib Drugs Production (2019-2024)
9.6.1 Japan Enasidenib Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Enasidenib Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Enasidenib Drugs Production (2019-2024)
9.7.1 China Enasidenib Drugs Production Growth Rate (2019-2024)
9.7.2 China Enasidenib Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Enasidenib Drugs Basic Information
10.1.2 Bristol Myers Squibb Enasidenib Drugs Product Overview
10.1.3 Bristol Myers Squibb Enasidenib Drugs Product Market Performance
10.1.4 Bristol Myers Squibb Business Overview
10.1.5 Bristol Myers Squibb Enasidenib Drugs SWOT Analysis
10.1.6 Bristol Myers Squibb Recent Developments
11 ENASIDENIB DRUGS MARKET FORECAST BY REGION
11.1 Global Enasidenib Drugs Market Size Forecast
11.2 Global Enasidenib Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Enasidenib Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Enasidenib Drugs Market Size Forecast by Region
11.2.4 South America Enasidenib Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Enasidenib Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Enasidenib Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Enasidenib Drugs by Type (2025-2032)
12.1.2 Global Enasidenib Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Enasidenib Drugs by Type (2025-2032)
12.2 Global Enasidenib Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Enasidenib Drugs Sales (K MT) Forecast by Application
12.2.2 Global Enasidenib Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Enasidenib Drugs
1.2 Key Market Segments
1.2.1 Enasidenib Drugs Segment by Type
1.2.2 Enasidenib Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ENASIDENIB DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Enasidenib Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Enasidenib Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ENASIDENIB DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Enasidenib Drugs Sales by Manufacturers (2019-2024)
3.2 Global Enasidenib Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Enasidenib Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Enasidenib Drugs Sales Sites, Area Served, Product Type
3.6 Enasidenib Drugs Market Competitive Situation and Trends
3.6.1 Enasidenib Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Enasidenib Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ENASIDENIB DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Enasidenib Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ENASIDENIB DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ENASIDENIB DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Enasidenib Drugs Sales Market Share by Type (2019-2024)
6.3 Global Enasidenib Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Enasidenib Drugs Price by Type (2019-2024)
7 ENASIDENIB DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Enasidenib Drugs Market Sales by Application (2019-2024)
7.3 Global Enasidenib Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Enasidenib Drugs Sales Growth Rate by Application (2019-2024)
8 ENASIDENIB DRUGS MARKET CONSUMPTION BY REGION
8.1 Global Enasidenib Drugs Sales by Region
8.1.1 Global Enasidenib Drugs Sales by Region
8.1.2 Global Enasidenib Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Enasidenib Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Enasidenib Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Enasidenib Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Enasidenib Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Enasidenib Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ENASIDENIB DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Enasidenib Drugs by Region (2019-2024)
9.2 Global Enasidenib Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Enasidenib Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Enasidenib Drugs Production
9.4.1 North America Enasidenib Drugs Production Growth Rate (2019-2024)
9.4.2 North America Enasidenib Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Enasidenib Drugs Production
9.5.1 Europe Enasidenib Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Enasidenib Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Enasidenib Drugs Production (2019-2024)
9.6.1 Japan Enasidenib Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Enasidenib Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Enasidenib Drugs Production (2019-2024)
9.7.1 China Enasidenib Drugs Production Growth Rate (2019-2024)
9.7.2 China Enasidenib Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Enasidenib Drugs Basic Information
10.1.2 Bristol Myers Squibb Enasidenib Drugs Product Overview
10.1.3 Bristol Myers Squibb Enasidenib Drugs Product Market Performance
10.1.4 Bristol Myers Squibb Business Overview
10.1.5 Bristol Myers Squibb Enasidenib Drugs SWOT Analysis
10.1.6 Bristol Myers Squibb Recent Developments
11 ENASIDENIB DRUGS MARKET FORECAST BY REGION
11.1 Global Enasidenib Drugs Market Size Forecast
11.2 Global Enasidenib Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Enasidenib Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Enasidenib Drugs Market Size Forecast by Region
11.2.4 South America Enasidenib Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Enasidenib Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Enasidenib Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Enasidenib Drugs by Type (2025-2032)
12.1.2 Global Enasidenib Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Enasidenib Drugs by Type (2025-2032)
12.2 Global Enasidenib Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Enasidenib Drugs Sales (K MT) Forecast by Application
12.2.2 Global Enasidenib Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Enasidenib Drugs Market Size Comparison by Region (M USD)
Table 5. Global Enasidenib Drugs Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Enasidenib Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Enasidenib Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Enasidenib Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enasidenib Drugs as of 2022)
Table 10. Global Market Enasidenib Drugs Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Enasidenib Drugs Sales Sites and Area Served
Table 12. Manufacturers Enasidenib Drugs Product Type
Table 13. Global Enasidenib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Enasidenib Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Enasidenib Drugs Market Challenges
Table 22. Global Enasidenib Drugs Sales by Type (K MT)
Table 23. Global Enasidenib Drugs Market Size by Type (M USD)
Table 24. Global Enasidenib Drugs Sales (K MT) by Type (2019-2024)
Table 25. Global Enasidenib Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Enasidenib Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Enasidenib Drugs Market Size Share by Type (2019-2024)
Table 28. Global Enasidenib Drugs Price (USD/MT) by Type (2019-2024)
Table 29. Global Enasidenib Drugs Sales (K MT) by Application
Table 30. Global Enasidenib Drugs Market Size by Application
Table 31. Global Enasidenib Drugs Sales by Application (2019-2024) & (K MT)
Table 32. Global Enasidenib Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Enasidenib Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Enasidenib Drugs Market Share by Application (2019-2024)
Table 35. Global Enasidenib Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Enasidenib Drugs Sales by Region (2019-2024) & (K MT)
Table 37. Global Enasidenib Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Enasidenib Drugs Sales by Country (2019-2024) & (K MT)
Table 39. Europe Enasidenib Drugs Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Enasidenib Drugs Sales by Region (2019-2024) & (K MT)
Table 41. South America Enasidenib Drugs Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Enasidenib Drugs Sales by Region (2019-2024) & (K MT)
Table 43. Global Enasidenib Drugs Production (K MT) by Region (2019-2024)
Table 44. Global Enasidenib Drugs Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Enasidenib Drugs Revenue Market Share by Region (2019-2024)
Table 46. Global Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Bristol Myers Squibb Enasidenib Drugs Basic Information
Table 52. Bristol Myers Squibb Enasidenib Drugs Product Overview
Table 53. Bristol Myers Squibb Enasidenib Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Bristol Myers Squibb Business Overview
Table 55. Bristol Myers Squibb Enasidenib Drugs SWOT Analysis
Table 56. Bristol Myers Squibb Recent Developments
Table 57. Global Enasidenib Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 58. Global Enasidenib Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 59. North America Enasidenib Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 60. North America Enasidenib Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 61. Europe Enasidenib Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 62. Europe Enasidenib Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 63. Asia Pacific Enasidenib Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 64. Asia Pacific Enasidenib Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 65. South America Enasidenib Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 66. South America Enasidenib Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 67. Middle East and Africa Enasidenib Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 68. Middle East and Africa Enasidenib Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 69. Global Enasidenib Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 70. Global Enasidenib Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 71. Global Enasidenib Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 72. Global Enasidenib Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 73. Global Enasidenib Drugs Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Enasidenib Drugs Market Size Comparison by Region (M USD)
Table 5. Global Enasidenib Drugs Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Enasidenib Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Enasidenib Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Enasidenib Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enasidenib Drugs as of 2022)
Table 10. Global Market Enasidenib Drugs Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Enasidenib Drugs Sales Sites and Area Served
Table 12. Manufacturers Enasidenib Drugs Product Type
Table 13. Global Enasidenib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Enasidenib Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Enasidenib Drugs Market Challenges
Table 22. Global Enasidenib Drugs Sales by Type (K MT)
Table 23. Global Enasidenib Drugs Market Size by Type (M USD)
Table 24. Global Enasidenib Drugs Sales (K MT) by Type (2019-2024)
Table 25. Global Enasidenib Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Enasidenib Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Enasidenib Drugs Market Size Share by Type (2019-2024)
Table 28. Global Enasidenib Drugs Price (USD/MT) by Type (2019-2024)
Table 29. Global Enasidenib Drugs Sales (K MT) by Application
Table 30. Global Enasidenib Drugs Market Size by Application
Table 31. Global Enasidenib Drugs Sales by Application (2019-2024) & (K MT)
Table 32. Global Enasidenib Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Enasidenib Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Enasidenib Drugs Market Share by Application (2019-2024)
Table 35. Global Enasidenib Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Enasidenib Drugs Sales by Region (2019-2024) & (K MT)
Table 37. Global Enasidenib Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Enasidenib Drugs Sales by Country (2019-2024) & (K MT)
Table 39. Europe Enasidenib Drugs Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Enasidenib Drugs Sales by Region (2019-2024) & (K MT)
Table 41. South America Enasidenib Drugs Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Enasidenib Drugs Sales by Region (2019-2024) & (K MT)
Table 43. Global Enasidenib Drugs Production (K MT) by Region (2019-2024)
Table 44. Global Enasidenib Drugs Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Enasidenib Drugs Revenue Market Share by Region (2019-2024)
Table 46. Global Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Bristol Myers Squibb Enasidenib Drugs Basic Information
Table 52. Bristol Myers Squibb Enasidenib Drugs Product Overview
Table 53. Bristol Myers Squibb Enasidenib Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Bristol Myers Squibb Business Overview
Table 55. Bristol Myers Squibb Enasidenib Drugs SWOT Analysis
Table 56. Bristol Myers Squibb Recent Developments
Table 57. Global Enasidenib Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 58. Global Enasidenib Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 59. North America Enasidenib Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 60. North America Enasidenib Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 61. Europe Enasidenib Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 62. Europe Enasidenib Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 63. Asia Pacific Enasidenib Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 64. Asia Pacific Enasidenib Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 65. South America Enasidenib Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 66. South America Enasidenib Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 67. Middle East and Africa Enasidenib Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 68. Middle East and Africa Enasidenib Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 69. Global Enasidenib Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 70. Global Enasidenib Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 71. Global Enasidenib Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 72. Global Enasidenib Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 73. Global Enasidenib Drugs Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Enasidenib Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Enasidenib Drugs Market Size (M USD), 2019-2032
Figure 5. Global Enasidenib Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Enasidenib Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Enasidenib Drugs Market Size by Country (M USD)
Figure 11. Enasidenib Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Enasidenib Drugs Revenue Share by Manufacturers in 2023
Figure 13. Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Enasidenib Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Enasidenib Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Enasidenib Drugs Market Share by Type
Figure 18. Sales Market Share of Enasidenib Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Enasidenib Drugs by Type in 2023
Figure 20. Market Size Share of Enasidenib Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Enasidenib Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Enasidenib Drugs Market Share by Application
Figure 24. Global Enasidenib Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Enasidenib Drugs Sales Market Share by Application in 2023
Figure 26. Global Enasidenib Drugs Market Share by Application (2019-2024)
Figure 27. Global Enasidenib Drugs Market Share by Application in 2023
Figure 28. Global Enasidenib Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Enasidenib Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Enasidenib Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Enasidenib Drugs Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Enasidenib Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Enasidenib Drugs Sales Market Share by Country in 2023
Figure 37. Germany Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Enasidenib Drugs Sales Market Share by Region in 2023
Figure 44. China Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 50. South America Enasidenib Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Enasidenib Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Enasidenib Drugs Production Market Share by Region (2019-2024)
Figure 62. North America Enasidenib Drugs Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Enasidenib Drugs Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Enasidenib Drugs Production (K MT) Growth Rate (2019-2024)
Figure 65. China Enasidenib Drugs Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Enasidenib Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Enasidenib Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Enasidenib Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Enasidenib Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Enasidenib Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Enasidenib Drugs Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Enasidenib Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Enasidenib Drugs Market Size (M USD), 2019-2032
Figure 5. Global Enasidenib Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Enasidenib Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Enasidenib Drugs Market Size by Country (M USD)
Figure 11. Enasidenib Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Enasidenib Drugs Revenue Share by Manufacturers in 2023
Figure 13. Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Enasidenib Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Enasidenib Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Enasidenib Drugs Market Share by Type
Figure 18. Sales Market Share of Enasidenib Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Enasidenib Drugs by Type in 2023
Figure 20. Market Size Share of Enasidenib Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Enasidenib Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Enasidenib Drugs Market Share by Application
Figure 24. Global Enasidenib Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Enasidenib Drugs Sales Market Share by Application in 2023
Figure 26. Global Enasidenib Drugs Market Share by Application (2019-2024)
Figure 27. Global Enasidenib Drugs Market Share by Application in 2023
Figure 28. Global Enasidenib Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Enasidenib Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Enasidenib Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Enasidenib Drugs Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Enasidenib Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Enasidenib Drugs Sales Market Share by Country in 2023
Figure 37. Germany Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Enasidenib Drugs Sales Market Share by Region in 2023
Figure 44. China Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 50. South America Enasidenib Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Enasidenib Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Enasidenib Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Enasidenib Drugs Production Market Share by Region (2019-2024)
Figure 62. North America Enasidenib Drugs Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Enasidenib Drugs Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Enasidenib Drugs Production (K MT) Growth Rate (2019-2024)
Figure 65. China Enasidenib Drugs Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Enasidenib Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Enasidenib Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Enasidenib Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Enasidenib Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Enasidenib Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Enasidenib Drugs Market Share Forecast by Application (2025-2032)
